维普期刊资源整合服务平台（V6.5）

36篇 您的检索式：作者名="Morton CL"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Establishment of human tumor xenografts in immunodeficient mice 显示文摘	Morton CL Houghton PJ	2007	Nat Protoc2007，2，2：	1
2	Isolation and partial characterization of a cDNA encoding a rabbit liver carboxyl-esterase that activates the prodrug irinotecan (CPT-11)显示文摘	Potter PM Pawik CA Morton CL	1998	Cancer Res1998，58，：	1
3	Comparison of activation of CPT-11 by rabbit and human carboxylesterase for use in enzyme/prodrug therapy显示文摘	Danks MK Morton CL Krull E J	1999	Clin Cancer Res1999，5，：	1
4	The pediatric preclinical testing program: description of models and early testing results 显示文摘	Houghton PJ Morton CL Tucker C	2007	Pediatr Blood Cancer2007，49，7：	1
5	Molecular characterization of the pediatric preclinical testing panel 显示文摘	Neale G Su X Morton CL	2008	Clin Cancer Res2008，14，14：	1
6	Effects of intestinal adaptation on insuin binding to villus cell membranes显示文摘	Young GP Morton CL rose IS	1987	Gut1987，28，：	1
7	Evaluation of ABT- 751 against childhood cancer models in vivo 显示文摘	Morton CL Favours EG Mercer KS	2007	Invest New Drugs2007，25，4：	1
8	Activation of CPT-11in mice: identification and analysis of a highly effective plasma esterase 显示文摘	Morton CL Wierdl M Oliver L	2000	Cancer Res2000，60，15：	1
9	Targeted disruption of mouse Coch pro-vides functional evidence that DFNA9 hearing loss is not aCOCH haploinsufficiency disorder显示文摘	Makishima T Rodriguez CI Robertson NG Morton CC Stewart CL Griffith AJ		0，，：	1
10	The anticancer prodrug CPT-11 is a potent inhibitor of acetylcholinesterase but is rapidly catalyzed to SN-38 by butyrylcholinesterase显示文摘	Morton CL Wadkins RM Danks MK	1999	Cancer Res1999，59，7：	1
11	Initial testing of topotecan by the pediatric preclinical testing program显示文摘	Carol H Houghton PJ Morton CL	2010	Pediatr Blood Cancer2010，54，5：	1
12	Establishment of human tumor xenografts in immunodeficient mice 显示文摘	Morton CL Houghton PJ	2007	Nat Protoc2007，2，2：	1
13	Establishment of human tumor xenografts in immunodeficient mice显示文摘	Morton CL Houghton PJ	2007	Nat Protoc2007，2，2：	1
14	Micromanipulation in assisted reproduction: a review of current technology显示文摘	Wright G Tucker M J Morton PC Sweitzer-Yoder CL Smith SE	1998	Curr Opin Obstet Gyne- col1998，10，：	1
15	Recommended tissue list for histopathologic examination in repeat-dose toxicity and carcinogenicity studies:A proposal of the society of toxicologic pathology (STP)显示文摘	Bregman CL Adler RR Morton DG	2003	Toxicol Pathol2003，31，2：	1
16	Initial testing (stage 1) of the mTOR inhibitor rapamycin by the pediat- ric preclinical testing program显示文摘	Houghton P J Morton CL Kolb EA	2008	Pediatr Blood Cancer2008，50，4：	1
17	The pediatric pre- clinical testing program: description of models and early testing results 显示文摘	Houghton PJ Morton CL Tucker C	2007	Pediatr Blood Cancer2007，49，7：	1
18	Characterization of inhibitors of specific carboxylesterases:development of carboxylesterase inhibitors for translational application显示文摘	Hyatt JL Morton CL	2004	Mol Cancer Ther2004，3，8：	1
19	N-Methyl-N-Nitrosourea (MNU): A positive control chemical for p53+/- mouse carci- nogenicity studies显示文摘	Morton D Bailey KL Stout CL et a/	2008	Toxicol Pathol2008，36，7：	1
20	Recommended tissue list for histopathologic examination in repeat-dose toxicity and caroinogenicity studies:a proposal of the Society of Toxicologic Pathology (STP)显示文摘	Bregman CL Adler RR Morton DG Regan KS Yano BL Society of Toxicologic Pathology	2003	Toxicol Pathol2003，31，2：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示